US Patent Issued to LUNELLA BIOTECH on Feb. 17 for "Energetic cancer stem cells (E-CSCS): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy" (British Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,092, issued on Feb. 17, was assigned to LUNELLA BIOTECH INC. (Ontario, Canada).

"Energetic cancer stem cells (E-CSCS): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy" was invented by Michael P. Lisanti (Didsbury Village, Great Britain), Federica Sotgia (Didsbury Village, Great Britain) and Marco Fiorillo (Manchester, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes the characteristics of the "energetic" cancer stem cell (e-CSC) phenotype. This distinct sub-population of cancer stem cells (CSCs) has a unique energetic profile compared to bulk CSCs, being more glycolit...